Medicare GLP-1 Bridge Program FAQ

Starting July 1, 2026, Medicare began covering certain GLP-1 weight-loss drugs under a new demonstration program called the Medicare GLP-1 Bridge. If you’ve been wondering whether Medicare will finally pay for Wegovy or Zepbound — the short answer is: yes, for qualifying enrollees, at a flat $50 copay. But the details matter. This FAQ covers exactly what the program covers, who qualifies, and what you need to know before asking your doctor for a prescription.

What Is the Medicare GLP-1 Bridge Program?

The Medicare GLP-1 Bridge is a Section 402 demonstration program run by the Centers for Medicare & Medicaid Services (CMS). It is not a permanent Medicare benefit and not a regulation — it is a time-limited pilot authorized under CMS’s demonstration authority.

The program allows Medicare Part D plans to cover three specific GLP-1 weight-loss drugs at a fixed $50 copay per 30-day supply, regardless of dosage. It operates completely outside the normal Part D benefit structure — plans are not exposed to financial risk, and they do not need to “opt in.” If you have Part D coverage, the Bridge applies automatically.

Which GLP-1 Drugs Are Covered?

Three drugs are covered under the Bridge. The prescription must be written for weight management — not for cardiovascular risk reduction or diabetes:

Who Is Eligible?

To access the Bridge, you must:

• Be enrolled in a Medicare Part D plan — a standalone PDP, an MA-PD (Medicare Advantage with drug coverage), an EGWP, or LI NET
• Have a prescription written for weight management (not cardiovascular risk reduction)
• Meet the BMI requirements for one of three eligibility tiers (see below)

Plans that do NOT qualify: PFFS (Private Fee-for-Service), PACE, Section 1876 cost plans, and RFB plans. Enrollees in these plans cannot access the Bridge.

What Are the BMI Requirements?

Eligibility is tiered by BMI at the time therapy is initiated, with additional clinical conditions required at lower BMI thresholds:

BMI is measured at the time the therapy is initiated. If your BMI drops below the threshold after you start, that does not automatically disqualify you from continued coverage under the Bridge.

How Much Does the GLP-1 Bridge Cost?

The copay is a flat $50 per 30-day supply, regardless of which of the three drugs you take or which dosage you’re on. This is the same whether you’re on the starting dose or a higher maintenance dose.

Important cost caveats to understand:

• The $50 does NOT count toward your Part D deductible
• The $50 does NOT count toward your annual out-of-pocket maximum ($2,100 in 2026)
• Extra Help / Low Income Subsidy (LIS) does NOT apply — low-income beneficiaries pay the full $50 just like everyone else

This is one of the most important things to understand: the Bridge operates outside the normal Part D structure, which means none of the standard cost protections (deductible, OOP cap, LIS) apply to Bridge claims.

Do I Need Prior Authorization?

Yes. Prior authorization is required for every Bridge prescription. Your prescriber submits the prior authorization request to a CMS central processor — not to your individual plan. The turnaround time is 72 hours for standard requests.

The prior authorization process verifies that you meet the BMI and clinical eligibility criteria and that the prescription is for weight management rather than another indication.

What If My Prior Authorization Is Denied?

The standard Part D appeals process does not apply to Bridge denials. CMS has established a separate review process for Bridge-specific denials, but it does not follow the same timelines and procedures as regular Part D coverage determinations and appeals. If your Bridge prior authorization is denied, speak with your prescriber about the specific reason — many denials are due to documentation gaps rather than outright ineligibility.

How Long Will the Program Last?

The Medicare GLP-1 Bridge demonstration runs from July 1, 2026 through December 31, 2027. There is no guarantee of continuation beyond that date.

The BALANCE Model — a proposed permanent pathway that would have required Medicare Advantage and Part D plans to cover GLP-1s for obesity — was indefinitely delayed as of April 21, 2026. No rescheduled date has been announced. As of July 2026, there is no confirmed legislative or regulatory path to permanent Medicare GLP-1 obesity coverage after the Bridge expires.

Do All Medicare Plans Participate Automatically?

Yes — for eligible plan types. Because the Bridge operates outside the standard Part D benefit, plans do not need to opt in and bear no financial risk. If you are enrolled in a PDP, MA-PD, EGWP, or LI NET plan, the Bridge is automatically available to you as long as you meet the eligibility criteria.

The only exceptions are the ineligible plan types: PFFS, PACE, Section 1876 cost plans, and RFB plans — enrollees in those plans cannot access Bridge pricing.

How Do I Get Started?

1. Talk to your doctor or healthcare provider about whether a covered GLP-1 drug is appropriate for your situation and whether you meet the BMI/clinical criteria
2. Your prescriber submits a prior authorization to the CMS central processor
3. If approved (within 72 hours for standard requests), your pharmacy will fill the prescription at the $50 Bridge copay
4. Make sure your prescriber documents the weight management indication — not a cardiovascular or diabetes indication — or the prescription will not qualify for Bridge pricing

Key Facts at a Glance

Sources: CMS.gov (last updated July 13, 2026); KFF.org (May 11, 2026); KFF Health News (May 6, 2026); Medicare Rights Center (June 4, 2026).